Institution
Summa Health System
Healthcare•Akron, Ohio, United States•
About: Summa Health System is a healthcare organization based out in Akron, Ohio, United States. It is known for research contribution in the topics: Population & Health care. The organization has 861 authors who have published 1141 publications receiving 42672 citations.
Topics: Population, Health care, Poison control, Heart failure, Cognition
Papers published on a yearly basis
Papers
More filters
••
University of Nebraska Medical Center1, University of Connecticut2, Harvard University3, Queen's University4, University of California, San Diego5, Stony Brook University6, University of Michigan7, National Institutes of Health8, Johns Hopkins University9, University of Barcelona10, University at Buffalo11, Summa Health System12, University of Texas Health Science Center at San Antonio13, Royal Brisbane and Women's Hospital14, University of Queensland15, University of Western Australia16, University of Colorado Denver17, McMaster University18
TL;DR: These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare providers caring for hospitalized patients with nosocomial pneumonia.
Abstract: It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. IDSA considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.These guidelines are intended for use by healthcare professionals who care for patients at risk for hospital-acquired pneumonia (HAP) and ventilator-associated pneumonia (VAP), including specialists in infectious diseases, pulmonary diseases, critical care, and surgeons, anesthesiologists, hospitalists, and any clinicians and healthcare providers caring for hospitalized patients with nosocomial pneumonia. The panel's recommendations for the diagnosis and treatment of HAP and VAP are based upon evidence derived from topic-specific systematic literature reviews.
2,359 citations
••
TL;DR: WBRT and stereotactic radiosurgery should, therefore, be standard treatment for patients with a single unresectable brain metastasis and considered for Patients with two or three brain metastases.
2,196 citations
••
TL;DR: It was decided that all of the information dealing with the initial empiric treatment regimens should be in tabular format with footnotes, and the topics selected for updating have been organized according to the headings used in the August 2000 CAP guidelines.
Abstract: The Infectious Diseases Society of America (IDSA) produced guidelines for community-acquired pneumonia (CAP) in immunocompetent adults in 1998 and again in 2000 [1, 2]. Because of evolving resistance to antimicrobials and other advances, it was felt that an update should be provided every few years so that important developments could be highlighted and pressing questions answered. We addressed those issues that the committee believed were important to the practicing physician, including suggestions for initial empiric therapy for CAP. In some cases, only a few paragraphs were needed, whereas, in others, a somewhat more in-depth discussion was provided. Because many physicians focus on the tables rather than on the text of guidelines, it was decided that all of the information dealing with the initial empiric treatment regimens should be in tabular format with footnotes (tables 1–3). The topics selected for updating have been organized according to the headings used in the August 2000 CAP guidelines pub-
949 citations
••
Advocate Lutheran General Hospital1, Radiation Therapy Oncology Group2, Fox Chase Cancer Center3, Saint Barnabas Medical Center4, University of California, San Francisco5, Cleveland Clinic6, Summa Health System7, Henry Ford Health System8, Mayo Clinic9, University of Texas MD Anderson Cancer Center10
TL;DR: Both regimens of palliative radiation therapy were equivalent in terms of pain and narcotic relief at 3 months and were well tolerated with few adverse effects.
Abstract: Background: Radiation therapy is effective in palliating pain from bone metastases. We investigated whether 8 Gy delivered in a single treatment fraction provides pain and narcotic relief that is equivalent to that of the standard treatment course of 30 Gy delivered in 10 treatment fractions over 2 weeks. Methods: A prospective, phase III randomized study of palliative radiation therapy was conducted for patients with breast or prostate cancer who had one to three sites of painful bone metastases and moderate to severe pain. Patients were randomly assigned to 8 Gy in one treatment fraction (8-Gy arm) or to 30 Gy in 10 treatment fractions (30-Gy arm). Pain relief at 3 months after randomization was evaluated with the Brief Pain Inventory. The Wilcoxon-Mann-Whitney test was used to compare response to treatment in terms of pain and narcotic relief between the two arms and for each stratification variable. All statistical comparisons were two-sided. Results: There were 455 patients in the 8-Gy arm and 443 in the 30-Gy arm; pretreatment characteristics were equally balanced between arms. Grade 2-4 acute toxicity was more frequent in the 30-Gy arm (17%) than in the 8-Gy arm (10%) (difference = 7%, 95% CI = 3% to 12%; P= .002). Late toxicity was rare (4%) in both arms. The overall response rate was 66%. Complete and partial response rates were 15% and 50%, respectively, in the 8-Gy arm compared with 18% and 48% in the 30-Gy arm (P = .6). At 3 months, 33% of all patients no longer required narcotic medications. The incidence of subsequent pathologic fracture was 5% for the 8-Gy arm and 4% for the 30-Gy arm. The retreatment rate was statistically significantly higher in the 8-Gy arm (18%) than in the 30-Gy arm (9%) (P<.001). Conclusions: Both regimens were equivalent in terms of pain and narcotic relief at 3 months and were well tolerated with few adverse effects. The 8-Gy arm had a higher rate of re-treatment but had less acute toxicity than the 30-Gy arm.
723 citations
••
TL;DR: Examination of attention and executive function in a cross-section of 408 healthy persons across the adult life span shows that BMI was inversely related to performance on all cognitive tests and suggests that this relationship does not vary with age.
640 citations
Authors
Showing all 867 results
Name | H-index | Papers | Citations |
---|---|---|---|
Stevan E. Hobfoll | 74 | 271 | 35870 |
Marc S. Penn | 57 | 197 | 13929 |
John Gunstad | 56 | 291 | 10867 |
Deepak P. Edward | 41 | 284 | 5763 |
Thomas M. File | 39 | 206 | 11822 |
Douglas L. Delahanty | 38 | 135 | 5524 |
Mary Beth Spitznagel | 38 | 150 | 4777 |
Patrick A. Palmieri | 38 | 83 | 5554 |
Kenneth R. Laurita | 36 | 90 | 5049 |
Joel W. Hughes | 35 | 135 | 4266 |
Chirag Shah | 34 | 341 | 5056 |
Lowell W. Gerson | 33 | 59 | 2994 |
Richard W. Hertle | 32 | 117 | 6644 |
Pedro Buc Calderon | 32 | 105 | 3502 |
Robert H. Bell | 32 | 77 | 3771 |